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Abstract  
 
The aim of this present study is to investigate the mucositis caused by methotrexate (MTX), as well as whether the 
application of royal jelly (RJ) has a protective effect on oxidative stress. This present study included six groups each 
consisted of 12 Wistar rats. Distilled water (po: peroral) was given to the 1st group as placebo for 10 days and MTX (20 
mg/kg, intraperitoneal: ip) on the 7th day. The 2nd group received RJ (50mg/kg, po) for 10 days and normal saline (NS) 
instead of MTX. RJ (50mg/kg) was given to the 3rd group for 10 days and MTX on the 7th day. The 4th group received RJ 
(100 mg/kg, po) for 10 days and NS was given intraperitoneally. RJ (100mg/kg) was given to the 5th group for 10 days and a 
single dose of MTX. Distilled water was given to the 6th (control) group for 10 days and intraperitoneal NS on the 7th day. 
Malondialdehyde (MDA), glutathione peroxidase and superoxide dismutase were analyzed in blood samples on the 11th day. 
Morphological and histopathological changes were examined in the intestinal tissue samples. Villus length and mucosal 
thickness, as well as the villus length/crypt ratio, were significantly decreased with MTX administration, and the semi-
quantitative histological evaluation (SQHE) score was measured high (p<0.001). In addition, a decrease in the antioxidant 
parameters and an increase in the MDA levels were identified. The villus length and SQHE were significantly different in the 
groups receiving RJ (p<0.001) as compared to the MTX group. Although RJ addition had no effect on the decreased mucosal 
thickness and villus/crypt ratio in MTX groups, it caused an improvement in the antioxidant levels and a remarkable decrease 
in MDA levels. Adding RJ has a decreasing effect on the MTX-induced intestinal damage and it has a suppressive effect on 
MTX-induced oxidative stress by means of increasing antioxidant enzyme activity and decreasing lipid peroxidation.  
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Introduction  
 
The damage caused by the chemotherapy (CT) and radiotherapy (RT) on the intestinal system is named as 
mucositis (Sonis et al., 2002). The severity of the mucositis ranges from mild inflammation to deep ulcerations (Blijlevens et 
al., 2000). The beginning step in the development of mucositis is the formation of reactive oxygen species (ROS); i.e. 
oxidative stress. Moreover, inflammation and bacterial colonization as well play an important role on the development steps 
of mucositis (Blijlevens et al., 2007). It has been shown that effective removal of the ROS in the patients receiving CT/RT 
decreases the development of mucositis (Culy et al., 2001). Royal jelly (RJ) is a bee product secreted from the 
hypopharyngeal glands of the young worker bees (Inoue et al., 2003). It has been demonstrated both in vitro studies and in 
vivo experimental rat studies that RJ has immunomodulatory (regulating) (Sver et al., 1996), anti-inflammatory (Kohno et al., 
2004), wound healing (Fujii et al., 1990), antioxidative (Jamnik et al., 2007) and antibacterial effects. These effects suggest 
that they might be beneficial in decreasing the development and treatment of mucositis.    
Methotrexate (MTX) is a chemotherapeutic agent that acts as a folate antagonist and likely causes severe mucositis 
(Chabner et al., 2007). MTX suppresses the antioxidative system and enhances oxidative stress in many organs (Babiak et al., 
1998). Therefore, RJ might have protective and decreasing effect on mucositis and oxidative stress. The present study was 
planned to investigate the effect of RJ on the methotrexate-induced mucositis and oxidative stress in rats. 
 
 
Materials and Methods 
 
This experimental study was conducted between September 2006 and September 2007 at the Hakan Çetinsaya 
Experimental and Clinical Research Center (ECRC) obtaining the approval of the ethical committee of Erciyes University 
School of Medicine.   
 
Animals 
 
Seventy-two male Wistar rats, each weighing 211-316 g, were included in the study. They were kept in special 
nests, each containing four rats, in the ventilated sunny rooms. Within seven days prior to the study, the rats were kept at 
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room temperature (22±2oC) in 12-hour natural light-12-hour dark cycle. They were fed with standard diet and given tap water 
as much as required. Water in the troughs was daily refreshed and the nests were cleaned every other day. After the seven-
day adaptation period, food restriction without water restriction was applied 12 hours prior to the study in order to provide 
similar metabolic condition.   
 
The source and the chemical analysis of royal jelly 
 
The royal jelly used in the study was obtained from Civan Arıcılık Co. The royal jelly was put in the deep-freezer 
immediately after being obtained, and stored at -18 ºC until being used in the study. The study standards were prepared daily, 
just before the analysis. The free amino-acid content of the RJ was identified with liquid chromatograph-mass spectrometry 
(Table 1). 
 
Creating study groups and the application of royal jelly and MTX 
 
Totally 72 animals were randomly divided into six groups each consisting of 12 rats. Oral distilled water was given 
to the 1st group (MTX) for 10 days and a single dose of MTX (20 mg/kg, ip) on the 7th day. The 2nd group (RJ50) received 
oral RJ (50 mg/kg) for 10 days and intraperitoneal normal saline on the 7th day instead of MTX. The 3rd group (MTX-RJ50) 
received oral RJ (50 mg/kg) for 10 days and a single dose of MTX (20 mg/kg, ip) on the 7th day. Oral RJ (100 mg/kg) was 
given to the 4th group (RJ100) for 10 days and intraperitoneal normal saline on the 7th day instead of MTX. (MTX-RJ100) 
Oral RJ (100 mg/kg) was given to the 5th group for 10 days and a single dose of MTX (20 mg/kg, ip) on 7th day; and the 6th 
group (control) received placebo for 10 days and intraperitoneal normal saline on the 7th day instead of MTX. RJ solution 
was given per oral together with equal amount of placebo (distilled water) via 3-inch 16-gauge lavage tube everyday at the 
same time. Similar to the previous models of MTX-induced mucositis, MTX was given at a dose of 20 mg/kg (Cetin et al., 
2008, Leung et al., 1997). 
 
The way that the samples obtained and their storage 
 
Since the maximum mucosal damage caused by MTX occurs after 72 hours (Yonei et al., 1997),, on the 11th day 72 
hours after the MTX administration, all the rats were sacrificed under  general anesthesia (50 mg/kg ketamine ip).  Just before 
they were sacrificed, 4-5 cc blood samples were obtained from each rat by intracardiac puncture and centrifuged at 3000 rpm 
for 10 minutes and the plasma was separated. Thereafter, the samples were stored at –80°C until the oxidative stress markers 
(malondialdehyde-MDA, glutathione peroxidase-GSH-Px, and superoxide dismutase-SOD) were studied. The intestines of 
the rats were removed for histological examination just after they have been sacrificed, and put in formalin after being 
washed with iced isotonic saline solution.   
 
Intestinal mucosa examination 
 
Duodenal tissues were cut and removed. On the histological examination performed after the routine tissue 
processing, villus length, mucosal thickness and the villus/crypt ratio were morphometrically evaluated analyzing the tissue 
sections stained with hematoxylin eosin (H&E) (Picture 1) (Carneıro-Fılho et el., 2004). The histopathological changes in the 
cells were examined via semi-quantitative histological evaluation (SQHE), which has been previously defined by Howarth et 
al. (Howarth et al., 1996). With this method, 11 parameters were evaluated including villus atrophy (blunting, fusion), 
superficial erythrocyte and brush-border destruction, decrease in the number of goblet cells, decrease in the number of 
mitotic figure, loss of crypt/structural deformation, destruction in crypt cells, crypt abscess, neutrophil infiltration, 
lymphocyte infiltration, lymphatic and capillary dilatation, thickening of submucosa and muscularis externa, and edema. For 
the duodenal tissue samples obtained from the rats, these histological variables were blindly scored from zero (normal) to 
three (maximum damage) by two pathologists considering the maximum value to be 33. 
 
The analysis of oxidative parameters 
 
Plasma MDA levels were measured using the method developed by Ohkawa et al. (Ohkawa et al., 1979). MDA 
reacts with thiobarbituric acid and produces fluorescent thiobarbituric acid reacting substances that are measured 
spectrophotometrically. The plasma SOD activity was identified with the method developed by Sun et al. (Sun et al., 1998), 
which is based on the measurement of the degree of nitroblue tetrazolium inhibition with xhantine-xhantine oxidase. The 
GSH-Px activity was identified in the plasma of the rats using the combined enzymatic method of Paglia et al (Paglia et al., 
1967). The principle of the method is based on the measurement of the speed of GSH-Px reaction, which catalysis the 
oxidation of glutathione by H2O2, over NAPDH concentration that is consumed during the glutathione disulphide reductase 
(GSSG-Rd) reaction. MDA levels, SOD activity and GSH-Px activity were in turn represented as nmol/ml, U/mg and U/L.  
 
Statistical analysis 
 
Kruskal-Wallis One Way Analysis of Variance and Dunn's test, one of the multiple comparison tests (Post Hoc 
Tests), were used to compare the groups in terms of the mean values of villus length, villus length/crypt ratio and the total 
score of SQHE. One-way analysis of variance (One-Way ANOVA) was used to compare the mean values of mucosa 
thickness, plasma MDA, GSH-Px and SOD and the Tukey's and Dunnett's t-test were used for the multiple comparison. The 
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data were represented as mean ± standard deviation ( SDx  ). A p value ≤0.05 was considered statistically significant. All  
data were analyzed using the Statistical Package for the Social Sciences (SPSS) computer program version 15.0.  
Results 
 
In the course of the study, two rats from the first group and one rat from the third group died 48 to 72 hours after 
the MTX administration. Diarrhea was observed in all rats in the first, third and fifth groups. Villus length, villus/crypt ratio 
and the mucosal thickness, morphometric measurements of the mucosa, and the results of SQHE, which were obtained via 
the morphometric analysis of the duodenal tissues of rats performed to evaluate the effect of RJ on the MTX-induced 
intestinal damage, are summarized in Table 2. The MDA levels and the data concerning GSH-Px and SOD activities are 
given oin Table 3.  
 
Table 1: Free amino acid content of the royal jelly (mg/100 g royal jelly)  
Free  
amino acid 
Royal jelly 
(mg/100 g) 
Free 
amino acid 
Royal jelly 
(mg/100 g) 
Aspartic acid 17.33 Cysteine 1.29 
Serine 1.39 Glutamic acid 2.99 
Glycine 1.66 Threonine 1.15 
Lysine 62.43 Alanine 1.14 
Proline 58.76 Tryptophan - 
Valine 3.29 Histidine - 
Methionine - Arginine - 
Tyrosine 1.29 Cystine 21.76 
Phenylalanine 1.49 Leucine-Isoleucine 1.51 
Hydroxyproline 1.61 Glutamine 1.46 
 
Table 2: Morphologic and histopathological intestinal parameters of the control and experiment groups  
Groups Mucosal thickness 
(mm) SDx   
Villus length 
(mm) SDx   
Villus 
length/crypt 
ratio SDx   
SQHE 
Total 
result SDx   
MTX (n=10) 0.17±0.05a 0.21±0.07a 2.33±0.55a 22.67±4.44a 
RJ50+MTX(n=11) 0.29±0.09ab 0.20±0.17a 3.16±1.99ab 10.70±0.05b 
RJ100+MTX (n=12) 0.37±0.10b 0.19±0.05a 3.41±0.9b 14.8±5.10b 
RJ 50 (n=12) 0.41±0.10b 0.35±0.62b 5.40±0.08c 4.33±2.81c 
RJ 100 (n=12) 0.47±0.13b 0.34±0.06b 4.79±1.44cd 3.00±1.55c 
Control (n=12) 0.42±0.15b 0.40±0.82b 4.39±0.89d 2.83±1.474c 
P <0.05 <0.001 <0.05 <0.001 
MTX; Methotrexate,  RJ; Royal Jelly,  SDx  ; mean ± standard deviation, SQHE; Semi-quantitative histological 
evaluation,  Alphabetical superscripts; same letters indicate the absence of statistical significance between the groups, means 
that they are similar; different letters indicate the presence of statistically significant difference between the groups, means 
that they are distinct.    
 
 
Table 3: Plasma MDA, SOD, and GSH-Px activities in the control and experiment groups  
Groups MDA (nmol/ml) 
SDx   
SOD (U/mg) 
SDx   
GPSHX (U/L)   
SDx   
MTX (n=10) 5.35±0.92a 14.98±1.23a 298.76±63.98a 
RJ50+MTX(n=11) 4.23±0.55b 17.15±1.17ab 375.48±66.82ac 
RJ100+MTX(n=12) 4.06±0.54b 18.36±1.41b 413.01±62.37acd 
RJ 50 (n=12) 2.57±0.39c 28.21±3.64c 492.12±70.6bc 
RJ 100 (n=12) 2.06±0.24c 32.98±3.48d 601.33±92.39b 
Control (n=12) 2.19±0.39c 26.85±3.09ce 534.59±74.39bd 
P <0.001 <0.001 <0.05 
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MTX; Methotrexate,  RJ; royal jelly, SSx  ; mean ± standard deviation, MDA; Malondialdehide,  
SOD; Superoxide dismutase, GSH-Px; Glutathione peroxidase. Alphabetical superscripts; same letters indicate the absence of 
statistical significance between the groups, means that they are similar; different letters indicate the presence of statistically 
significant difference between the groups, means that they are distinct 
 
 
Picture 1: The histopathological effect of RJ added in the diet on the intraperitoneal MTX-induced intestinal damage in rats. 
A-B (control group), E-F (RJ50 group), and G-H (RJ50-MTX group) are the sections that have normal 
morphological view; C and D (MTX group); branching and deepening of the villi is shown on C (arrow), crypt 
abscess and loss of goblet cells are shown on D (arrow). G,H (RJ50-MTX group) and K,L (RJ100-MTX group); 
less blunting of the villi and no remarkable loss of goblet cells were observed. 
 
 
 
 
 
Discussion 
 
It has been definitely shown that MTX therapy causes oral and intestinal mucositis in patients. Rats as well, are 
suitable models for the MTX-induced gastrointestinal mucositis (GIM) (Howarth et al., 1996). In this present study, diarrhea 
was observed in all of the study groups that underwent MTX therapy. A possible diarrhea protecting effect of RJ in the RJ50-
MTX and RJ100-MTX groups was negative.  
Shortening in the villus length, as well as the decrease in the mucosal thickness and villus length/crypt ratio, is 
likely to occur in the MTX-induced mucositis models in rats (De Koning et al., 2007). Similarly, in this present study, 
mucosal thickness and villus length/crypt ratio were found decreased and the villus length was found shortened in the MTX 
groups as compared to the control group (p<0.001). In the multiple comparisons of the groups, no statistical difference was 
found in mucosal thickness between the RJ100-MTX group and the control group. The mean value of mucosal thickness in 
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RJ50-MTX group was better the MTX group, but no difference was determined between RJ50-MTX group and the MTX 
group. This result suggests that dose of 100 mg/kg RJ is more effective than 50 mg/kg. RJ has dose dependent protective 
effect on the mucosal thickness. 
The high total score that was measured by the semi-quantitative histological evaluation was significantly decreased 
in the groups in which RJ has been added to the MTX therapy.  
The result of histological evaluations, show that, oral RJ administration with the dose used in the rats had no toxic effect on 
the intestinal mucosa, but had relieving effect on the MTX-induced mucositis particularly at a dose of 100mg. Initially in 
mucositis development, direct DNA damage caused by the CT and RT might lead to cellular death in the basal epithelium 
and submucosal cells, but clonal cell death occurs in only small part of the damaged cells. However, this is inadequate to 
explain the intensive damage, which is the clinical manifestation of the mucositis. More importantly, CT and RT lead to the 
formation of reactive oxygen species (ROS) during the therapy. ROS damage the connective tissue as well as DNA and cell 
membrane, stimulates macrophages, and triggers the critical biological mechanisms, molecules and the pathways (Sonis et 
al., 2007). In conclusion, CT, RT and ROS cause a biological formation that results in mucosal damage by directly or 
indirectly triggering too many signal pathways (Sonis et al., 2004). Release of the proinflammatory cytokines, increase in the 
epithelial and submucosal apoptosis, ulceration and bacterial transmission, and finally healing is the expected progression of 
this formation. Since the ROS are considered in such a central place in the development of mucositis, which occurs as the 
result of cancer therapy, they become the focus of the studies performed on the prevention and treatment of mucositis. Under 
normal conditions, there is a balance between the production and destruction of ROS. Oxidative stress is defined as the shift 
of the balance between the oxygen radicals and the protective antioxidant defense system in  favor of radicals (Akkus et al., 
1995).   
In this present study, the plasma MDA levels were found significantly higher in the MTX group as compared to the 
control group. This corroborates the suggestion that MTX therapy leads to remarkably high rates of lipid peroxidation in the 
plasma. Although the MDA level was higher in the MTX group than the control group, it was found significantly lower in the 
RJ50-MTX and RJ100-MTX groups as compared to the MTX group. These results suggest that RJ has protective effect 
against lipid peroxidation in the MTX-induced systemic oxidative damage. Thus, it can be assumed that the increase in 
cellular permeability and inflammation, arachidonic acid release, and consequently organelle swelling and membrane rupture 
that are caused by the MDA and other lipid peroxidation products can be prevented.   
The antioxidant efficacy of RJ has been evaluated in various studies. Both in the study performed by Kanbur et al. 
and in the study performed by El-Nekeety et al., it was reported that antioxidative enzymes are significantly higher in the 
groups given RJ as compared to the other study groups (El-Nekeety et al., 2007, Kanbur et al., 2009a, Kanbur et al., 2009b). 
In this present study, both enzyme activities were significantly decreased in the MTX group (Table 2). Although it was not 
found statistically significant, there was an increase in the activities of both enzymes in the RJ50-MTX group. The SOD 
activity was significantly higher in the RJ100-MTX group as compared to MTX group; the GSH-Px activity was higher as 
well, but this increase was not statistically significant. Interestingly, SOD and GSH-Px activities were found remarkably 
higher only in the RJ100 group as compared to the control group. Whereas the increase in SOD activity was statistically 
significant (p<0.001), the increase in GSH-Px activity was not (p>0.05). These results corroborate that RJ increases the 
activity of antioxidative enzymes both under normal physiological conditions and in the presence of oxidative stress. Increase 
in the enzyme activity becomes more conspicuous as the dose of RJ is increased. This suggests that increase in the activities 
of antioxidative enzymes would become more remarkable if high dose of RJ is applied together with MTX.   
Taking all of these outcomes into consideration in the chain of the events that lead to MTX-induced mucositis in 
rats, in which oxidative stress plays an important role, it can be thought that RJ suppresses the oxidative stress and decreases 
the MTX-induced intestinal damage by means of increasing the activities of antioxidant enzymes and decreasing the lipid 
peroxidation. The results suggest that, better outcomes can be obtained with higher doses of RJ.  
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